https://www.selleckchem.com/pr....oducts/trastuzumab-d
levels of resilience. HRQoL was greater in women who lived with others. The objectives of this study were to evaluate the feasibility and efficacy of fractional CO laser therapy in gynecologic cancer survivors. This was a pilot, multi-institutional randomized sham-controlled trial of women with gynecologic cancers with dyspareunia and/or vaginal dryness. Participants were randomized to fractional CO laser treatment or sham laser treatment. The primary aim was to estimate the proportion of patients who had improvement in s
Curtir
Comentario
Compartilhar
